Thyroid hormone receptor Thra and Thrb knockout differentially affects osteoblast biology and thyroid hormone responsiveness in vitro

Abstract

Thyroid hormones (TH) are important modulators of bone remodeling and thus, thyroid diseases, in particular hyperthyroidism, are able to compromise bone quality and fracture resistance. TH actions on bone are mediated by the thyroid hormone receptors (TR) TRα1 and TRβ1, encoded by Thra and Thrb, respectively. Skeletal phenotypes of mice lacking Thra (Thra0/0) and Thrb (Thrb−/−) are well‐described and suggest that TRα1 is the predominant mediator of TH actions in bone. Considering that bone cells might be affected by systemic TH changes seen in these mutant mice, here we investigated the effects of TR knockout on osteoblasts exclusively at the cellular level. Primary osteoblasts obtained from Thra0/0, Thrb−/−, and respective wildtype (WT) mice were analyzed regarding their differentiation potential, activity and TH responsiveness in vitro. Thra, but not Thrb knockout promoted differentiation and activity of early, mature and late osteoblasts as compared to respective WT cells. Interestingly, while mineralization capacity and expression of osteoblast marker genes and TH target gene Klf9 was increased by TH in WT and Thra‐deficient osteoblasts, Thrb knockout mitigated the responsiveness of osteoblasts to short (48 h) and long term (10 d) TH treatment. Further, we found a low ratio of Rankl, a potent osteoclast stimulator, over osteoprotegerin, an osteoclast inhibitor, in Thrb‐deficient osteoblasts and in line, supernatants obtained from Thrb−/− osteoblasts reduced numbers of primary osteoclasts in vitro. In accordance to the increased Rankl/Opg ratio in TH‐treated WT osteoblasts only, supernatants from these cells, but not from TH‐treated Thrb−/− osteoblasts increased the expression of Trap and Ctsk in osteoclasts, suggesting that osteoclasts are indirectly stimulated by TH via TRβ1 in osteoblasts. In conclusion, our study shows that both Thra and Thrb differentially affect activity, differentiation and TH response of osteoblasts in vitro and emphasizes the importance of TRβ1 to mediate TH actions in bone.

Hyperthyroidism-driven bone loss depends on BMP receptor Bmpr1a expression in osteoblasts

“…To conduct indirect coculture experiments, supernatants were collected from over 10 days differentiated Cre-negative and Cre-positive Bmpr1a fl/fl ;Osx-Cre osteoblasts that were cultured beforehand with or w/o 100 nM T 3 over 48 h in a-MEM with 1% FCS and 1% P/S. To obtain osteoclasts as reported before 76 . bone marrow cells from long bones of 12-week-old male C57BL/ 6JRj were cultured in a-MEM supplemented with 10% FCS, 1% P/S, 2 mM L-glutamine and 10 ng/ml macrophage colony-stimulating factor (MCSF, from R&D Systems, Minneapolis, USA) over 24 h in a cell culture flask.…”